


Healthcare News Roundup: Oncology
HSMN NewsFeed - 11 Mar 2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
HSMN NewsFeed - 5 Mar 2021
Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy
Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy
HSMN NewsFeed - 22 Feb 2021
Elekta establishes office in Egypt to meet growing need for precision radiation medicine
Elekta establishes office in Egypt to meet growing need for precision radiation medicine
HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 10 Feb 2021
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
HSMN NewsFeed - 8 Feb 2021
SmartBreast(TM) Acquires Molecular Breast Imaging Assets from GE Healthcare
SmartBreast(TM) Acquires Molecular Breast Imaging Assets from GE Healthcare
HSMN NewsFeed - 5 Feb 2021
Jubilant Therapeutics Appoints Dr. Robert Glassman to its Board of Directors
Jubilant Therapeutics Appoints Dr. Robert Glassman to its Board of Directors
HSMN NewsFeed - 26 Jan 2021
The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian(R) Linac
The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian(R) Linac
HSMN NewsFeed - 19 Jan 2021
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
HSMN NewsFeed - 18 Jan 2021
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
